国外黄色大片久久久免费,99精品视频69v精品视频

(E/Z)-Tamoxifen-d5

NMR下載 COA and HPLC MSDS下載
names：
(E/Z)-Tamoxifen-d5
CAS號(hào)：
157698-32-3
MDL Number：
MF(分子式)： C26H29NO2 MW(分子量)： 387.514
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

貨品編碼	規(guī)格	純度	價(jià)格 (￥)	現(xiàn)價(jià)(￥)	特價(jià)(￥)	庫存描述	數(shù)量	總計(jì) (￥)
HCC345955-1mg	1mg	97%	￥ 1862.00	￥ 1862.00		4-7周	- +	￥ 0.00

大包裝詢價(jià) 提供各種包裝，敬請(qǐng)垂詢
收藏商品商品點(diǎn)評(píng) 加入購物車立即購買

快速詢價(jià)

收起

你想詢價(jià)的產(chǎn)品

*產(chǎn)品名稱：

CAS號(hào)：

產(chǎn)品編號(hào)：

需求描述：

請(qǐng)準(zhǔn)確填寫您的聯(lián)系方式，以便為您提供最好的服務(wù)。

*公司名稱：

*電子郵箱：

聯(lián)系人：

*電話：

*驗(yàn)證碼：

詢價(jià)

中文別名	(E/Z)-Tamoxifen-d5;(157698-32-3)
英文別名	157698-32-3;(E/Z)-Tamoxifen-d5
CAS號(hào)	157698-32-3
Inchi	InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25-
InchiKey	TXUZVZSFRXZGTL-QPLCGJKRSA-N
分子式 Formula	C26H29NO2
分子量 Molecular Weight	387.514
溶解度Solubility	Methanol (Slightly)
性狀
儲(chǔ)藏條件 Storage conditions	-20°C Freezer, Under Inert Atmosphere

實(shí)驗(yàn)注意事項(xiàng)：
1.實(shí)驗(yàn)前需戴好防護(hù)眼鏡，穿戴防護(hù)服和口罩，佩戴手套，避免與皮膚接觸。
2.實(shí)驗(yàn)過程中如遇到有毒或者刺激性物質(zhì)及有害物質(zhì)產(chǎn)生，必要時(shí)實(shí)驗(yàn)操作需要手套箱內(nèi)完成以免對(duì)實(shí)驗(yàn)人員造成傷害
3.實(shí)驗(yàn)后產(chǎn)生的廢棄物需分類存儲(chǔ)，并交于專業(yè)生物廢氣物處理公司處理，以免造成環(huán)境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.

產(chǎn)品說明	(E/Z)-Tamoxifen-d5;(157698-32-3)可以作為藥物雜質(zhì)對(duì)照品以及生物醫(yī)藥類試劑。
Introduction	157698-32-3;(E/Z)-Tamoxifen-d5 can be used as a reference substance for drug impurities and reagents，only for research.
Application1
Application2
Application3

警示圖
危險(xiǎn)性	warning
危險(xiǎn)性警示	Not available
安全聲明	H303+H313+H333
安全防護(hù)	P264+P280+P305+P351+P338+P337+P313
備注	實(shí)驗(yàn)過程中防止吸入、食入，做好安全防護(hù)

Dennis et al..In vivo effects of a GPR30 antagonist,Nature Chemical Biology, 2009[DOI: 10.1038nchembio.168]

Irena Efremenko, Siden Top, Jan M. L. Martin and Richard H. Fish.A DFT study on the mechanism of a novel, regioselective, intramolecular N–π rearrangement of cis and trans-η1-N-Cp*Rh-hydroxytamoxifen complexes to their η derivatives; potential breast cancer pharmaceuticals, and fluorescent probes,Dalton Trans., 2009, 4334.[DOI: 10.1039b819474b]

Lv Wei, Liu Jinzhong, Lu Deshun, Flockhart David A., Cushman Mark.Synthesis of Mixed (E,Z)-, (E)-, and (Z)-Norendoxifen with Dual Aromatase Inhibitory and Estrogen Receptor Modulatory Activities,Journal of Medicinal Chemistry, 2013[DOI: 10.1021jm400364h]

Cerra Bruno, Mostarda Serena, Custodi Chiara, Macchiarulo Antonio, Gioiello Antimo.Integrating multicomponent flow synthesis and computational approaches for the generation of a tetrahydroquinoline compound based library,Med. Chem. Commun., 2016[DOI: 10.1039C5MD00455A]

Luo Junjie, Hu Zhiye, Xiao Yuan, Yang Tongxin, Dong Chune, Huang Jian, Zhou Hai-Bing.Rational design and optimization of selenophenes with basic side chains as novel potent selective estrogen receptor modulators (SERMs) for breast cancer therapy,Med. Chem. Commun., 2017[DOI: 10.1039C7MD00163K]

對(duì)不起，暫無產(chǎn)品評(píng)價(jià)！

MSDS

SDS 1.0 中文

展開

SDS 1.0 英文

展開